GraphTX

GraphTx (also known as Graph Therapeutics) is a precision immunology techbio company headquartered in Vienna, Austria, that uses a proprietary perturbation modeling platform to decode complex immune dysfunction. The company captures live primary patient immune cell behavior and combines it with multi-omics data to identify causal drivers of inflammatory and immune-mediated diseases, enabling the development of targeted therapies and biomarkers. GraphTx operates a lab-in-the-loop AI system that bridges functional profiling, computational modeling, and clinical drug discovery. With over $10 million raised to date, the company has transitioned from a validated research platform to an internal drug discovery engine targeting conditions such as rheumatoid arthritis and systemic inflammation.